Cerebrovascular and Neurological Disorders: Protective Role of NRF2
暂无分享,去创建一个
[1] Jing Chen,et al. Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress , 2020, Oxidative medicine and cellular longevity.
[2] Cecilia Prata,et al. Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration , 2020, International journal of molecular sciences.
[3] P. Boya,et al. Age related retinal Ganglion cell susceptibility in context of autophagy deficiency , 2020, Cell Death Discovery.
[4] Farzane Sivandzade,et al. Traumatic Brain Injury and Blood–Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition , 2020, International journal of molecular sciences.
[5] Farzane Sivandzade,et al. The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo study , 2019, Journal of Neuroinflammation.
[6] Hongping Chen,et al. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. , 2019, Life sciences.
[7] Farzane Sivandzade,et al. Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke-induced blood–brain barrier impairment , 2019, BMC Neuroscience.
[8] N. Chondrogianni,et al. Sulforaphane - role in aging and neurodegeneration , 2019, GeroScience.
[9] J. Filosa,et al. NLRP3 inflammasome inhibition with MCC950 improves diabetes‐mediated cognitive impairment and vasoneuronal remodeling after ischemia , 2019, Pharmacological research.
[10] W. Liang,et al. Expression of nuclear factor erythroid 2-related factor 2 following traumatic brain injury in the human brain , 2019, Neuroreport.
[11] S. Doré,et al. Critical Role of Nrf2 in Experimental Ischemic Stroke , 2019, Front. Pharmacol..
[12] S. Shultz,et al. Affective, neurocognitive and psychosocial disorders associated with traumatic brain injury and post-traumatic epilepsy , 2019, Neurobiology of Disease.
[13] Lin Zhu,et al. Activation of the Nrf2-ARE signal pathway after blast induced traumatic brain injury in mice , 2019, The International journal of neuroscience.
[14] Leilei Mao,et al. Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] Farzane Sivandzade,et al. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches , 2018, Redox biology.
[16] A. Silva-Palacios,et al. Nrf2: Molecular and epigenetic regulation during aging , 2018, Ageing Research Reviews.
[17] L. Cucullo,et al. In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity , 2018, Scientific Reports.
[18] Farzane Sivandzade,et al. Conventional and electronic cigarettes dysregulate the expression of iron transporters and detoxifying enzymes at the brain vascular endothelium: In vivo evidence of a gender-specific cellular response to chronic cigarette smoke exposure , 2018, Neuroscience Letters.
[19] Farzane Sivandzade,et al. In-vitro blood–brain barrier modeling: A review of modern and fast-advancing technologies , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] A. I. Rojo,et al. Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A , 2018, Autophagy.
[21] A. I. Rojo,et al. Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy , 2018, Redox biology.
[22] R. de Cabo,et al. Nrf2 Deficiency Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood–Brain Barrier Disruption, Neuroinflammation, Amyloidogenic Gene Expression, and Cognitive Decline in Mice, Mimicking the Aging Phenotype , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.
[23] M. Nakazato,et al. Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1 , 2018, FEBS open bio.
[24] R. Donato,et al. Nrf2-Keap1 signaling in oxidative and reductive stress. , 2018, Biochimica et biophysica acta. Molecular cell research.
[25] J. Pi,et al. Curcumin plays neuroprotective roles against traumatic brain injury partly via Nrf2 signaling , 2018, Toxicology and applied pharmacology.
[26] H. Solleiro-Villavicencio,et al. Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases , 2018, Front. Cell. Neurosci..
[27] J. Zhao,et al. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury , 2018, Behavioural Brain Research.
[28] X. He,et al. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice , 2017, Brain, Behavior, and Immunity.
[29] L. Cucullo,et al. Unhealthy smokers: scopes for prophylactic intervention and clinical treatment , 2017, BMC Neuroscience.
[30] L. Cucullo,et al. Blood-brain barrier disruption in diabetic mice is linked to Nrf2 signaling deficits: Role of ABCB10? , 2017, Neuroscience Letters.
[31] S. Lovestone,et al. NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology , 2017, Redox biology.
[32] A. I. Rojo,et al. NRF2 controls proteostasis through the transcriptional regulation of autophagy , 2017 .
[33] T. Abbruscato,et al. Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure? , 2017, Redox biology.
[34] E. Mikiciuk-Olasik,et al. Metformin – a Future Therapy for Neurodegenerative Diseases , 2017, Pharmaceutical Research.
[35] V. Krajka-Kuźniak,et al. The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment , 2017, Pharmacological reports : PR.
[36] Yanghao Hou,et al. Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats , 2017, International immunopharmacology.
[37] Leena Kadam,et al. Rosiglitazone Regulates TLR4 and Rescues HO-1 and NRF2 Expression in Myometrial and Decidual Macrophages in Inflammation-Induced Preterm Birth , 2017, Reproductive Sciences.
[38] Makoto Kobayashi,et al. Conservation of the Keap1-Nrf2 System: An Evolutionary Journey through Stressful Space and Time , 2017, Molecules.
[39] G. Deeb,et al. Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury , 2017, Front. Neurol..
[40] T. Abbruscato,et al. Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity , 2017, Redox biology.
[41] M. Mishra,et al. Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2 , 2017, Free radical biology & medicine.
[42] S. Salim,et al. Oxidative Stress and the Central Nervous System , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[43] X. Zhao,et al. Sulforaphane activates the cerebral vascular Nrf2–ARE pathway and suppresses inflammation to attenuate cerebral vasospasm in rat with subarachnoid hemorrhage , 2016, Brain Research.
[44] P. Evans,et al. Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways. , 2016, Vascular pharmacology.
[45] Manisha N. Patel. Targeting Oxidative Stress in Central Nervous System Disorders. , 2016, Trends in pharmacological sciences.
[46] S. Kügler,et al. Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease. , 2016, Antioxidants & redox signaling.
[47] N. Suwanwela,et al. Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R. , 2016, Microvascular research.
[48] Xupeng Bai,et al. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters , 2016, Drug metabolism reviews.
[49] H. Hara,et al. Nrf2 activator ameliorates hemorrhagic transformation in focal cerebral ischemia under warfarin anticoagulation , 2016, Neurobiology of Disease.
[50] T. Kensler,et al. Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane. , 2016, Seminars in oncology.
[51] H. D. de Vries,et al. Morphogens and blood-brain barrier function in health and disease , 2016, Tissue barriers.
[52] Qin M. Chen,et al. Nrf2 protects mitochondrial decay by oxidative stress , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] Ying Huang,et al. The complexity of the Nrf2 pathway: beyond the antioxidant response. , 2015, The Journal of nutritional biochemistry.
[54] L. Cucullo,et al. Protecting the BBB endothelium against cigarette smoke-induced oxidative stress using popular antioxidants: Are they really beneficial? , 2015, Brain Research.
[55] A. Dinkova-Kostova,et al. The emerging role of Nrf2 in mitochondrial function , 2015, Free radical biology & medicine.
[56] C. Mozzini,et al. Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases. , 2015, Free radical biology & medicine.
[57] K. Davies,et al. Oxidative stress response and Nrf2 signaling in aging. , 2015, Free radical biology & medicine.
[58] Takafumi Suzuki,et al. Molecular basis of the Keap1-Nrf2 system. , 2015, Free radical biology & medicine.
[59] L. Cucullo,et al. Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products , 2015, Fluids and Barriers of the CNS.
[60] F. Cabreiro,et al. Repurposing metformin: an old drug with new tricks in its binding pockets , 2015, The Biochemical journal.
[61] C. Sanderson,et al. Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways , 2015, Biochemical Society transactions.
[62] L. Cucullo,et al. Impact of cigarette smoke extract and hyperglycemic conditions on blood–brain barrier endothelial cells , 2015, Fluids and Barriers of the CNS.
[63] L. Cucullo,et al. Effect of full flavor and denicotinized cigarettes exposure on the brain microvascular endothelium: a microarray-based gene expression study using a human immortalized BBB endothelial cell line , 2015, BMC Neuroscience.
[64] F. Khodagholi,et al. Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia , 2015, Metabolic Brain Disease.
[65] R. Piperno,et al. Traumatic Brain Injury and NADPH Oxidase: A Deep Relationship , 2015, Oxidative medicine and cellular longevity.
[66] L. Cucullo,et al. Altered Nrf2 Signaling Mediates Hypoglycemia-Induced Blood–Brain Barrier Endothelial Dysfunction In Vitro , 2015, PloS one.
[67] Han-dong Wang,et al. Deletion of Nrf2 Exacerbates Oxidative Stress After Traumatic Brain Injury in Mice , 2015, Cellular and Molecular Neurobiology.
[68] S. H. Young,et al. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells , 2014, PloS one.
[69] R. Pi,et al. Osthole, a Natural Coumarin Improves Cognitive Impairments and BBB Dysfunction After Transient Global Brain Ischemia in C57 BL/6J Mice: Involvement of Nrf2 Pathway , 2014, Neurochemical Research.
[70] Guo-Yuan Yang,et al. Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion , 2014, Journal of Neuroinflammation.
[71] L. Gan,et al. Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. , 2014, Biochimica et biophysica acta.
[72] Jin He,et al. Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. , 2014, Free radical biology & medicine.
[73] Jian Cheng,et al. Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke , 2014, Brain, Behavior, and Immunity.
[74] H. Koh,et al. Rosiglitazone inhibits chlorpyrifos-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells. , 2014, Toxicology and applied pharmacology.
[75] Xueqian Wang,et al. Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood–Brain and Blood–Spinal Cord Barriers , 2014, The Journal of Neuroscience.
[76] G. K. Rajanikant,et al. Calcium ion--the key player in cerebral ischemia. , 2014, Current medicinal chemistry.
[77] A. Cuadrado,et al. Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation* , 2014, The Journal of Biological Chemistry.
[78] Xinyu Lu,et al. Genetic elimination of Nrf2 aggravates secondary complications except for vasospasm after experimental subarachnoid hemorrhage in mice , 2014, Brain Research.
[79] J. Hayes,et al. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.
[80] S. Weber,et al. NRF2-regulation in brain health and disease: Implication of cerebral inflammation , 2014, Neuropharmacology.
[81] Luca Cucullo,et al. Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. , 2014, Journal of pharmacovigilance.
[82] Akhileshwar Namani,et al. Nrf2: bane or blessing in cancer? , 2014, Journal of Cancer Research and Clinical Oncology.
[83] Dong Jin Kim,et al. Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy. , 2014, Journal of medicinal chemistry.
[84] L. Cui,et al. Bicyclol upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia , 2014, Brain Research Bulletin.
[85] W. Wang,et al. Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure , 2014, Brain Research.
[86] S. Niture,et al. Regulation of Nrf2-an update. , 2014, Free radical biology & medicine.
[87] A. Suzuki,et al. Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers , 2013, Molecular and Cellular Biology.
[88] Hung-Chuan Pan,et al. Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. , 2013, The Journal of nutritional biochemistry.
[89] Steven C. R. Williams,et al. Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke. , 2013, Free radical biology & medicine.
[90] T. Mizushima,et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. , 2013, Molecular cell.
[91] Steven Finkbeiner,et al. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. , 2013, Nature chemical biology.
[92] P. Stenvinkel,et al. Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. , 2013, Biochimie.
[93] A. Higginbottom,et al. S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis☆ , 2013, Free radical biology & medicine.
[94] E. Mercken,et al. Metformin improves healthspan and lifespan in mice , 2013, Nature Communications.
[95] P. Hrelia,et al. Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases , 2013, Oxidative medicine and cellular longevity.
[96] Ye Xu,et al. Regulation of endoplasmic reticulum stress in rat cortex by p62/ZIP through the Keap1-Nrf2-ARE signalling pathway after transient focal cerebral ischaemia , 2013, Brain injury.
[97] Masayuki Yamamoto,et al. Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration , 2013, Biology Open.
[98] Junxia Xie,et al. Role of α-synuclein aggregation and the nuclear factor E2-related factor 2/heme oxygenase-1 pathway in iron-induced neurotoxicity. , 2013, The international journal of biochemistry & cell biology.
[99] Joshua A. Smith,et al. Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration , 2013, Neurochemistry International.
[100] C. Goldring,et al. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. , 2013, Biochemical pharmacology.
[101] He-Jin Lee,et al. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein. , 2013, Antioxidants & redox signaling.
[102] G. Johnson,et al. Impaired Mitochondrial Dynamics and Nrf2 Signaling Contribute to Compromised Responses to Oxidative Stress in Striatal Cells Expressing Full-Length Mutant Huntingtin , 2013, PloS one.
[103] L. Cui,et al. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice , 2013, Brain Research.
[104] Dong Jin Kim,et al. Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model , 2013, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[105] L. C. Pomatto,et al. Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging , 2013, Redox biology.
[106] A. Levonen,et al. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer☆ , 2013, Redox biology.
[107] A. Kakita,et al. Keap1 Is Localized in Neuronal and Glial Cytoplasmic Inclusions in Various Neurodegenerative Diseases , 2013, Journal of neuropathology and experimental neurology.
[108] L. Gan,et al. Astrocyte-Specific Overexpression of Nrf2 Delays Motor Pathology and Synuclein Aggregation throughout the CNS in the Alpha-Synuclein Mutant (A53T) Mouse Model , 2012, The Journal of Neuroscience.
[109] S. Hadano,et al. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS. , 2012, Free radical biology & medicine.
[110] M. Picklo,et al. The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. , 2012, The Journal of nutritional biochemistry.
[111] Q. Ma,et al. Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2 , 2012, Pharmacological Reviews.
[112] G. K. Rajanikant,et al. Oxidative stress--assassin behind the ischemic stroke. , 2012, Folia neuropathologica.
[113] S. Petri,et al. Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS , 2012, Neurology research international.
[114] R. Gold,et al. Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters , 2012, International journal of molecular sciences.
[115] Xue-bo Sun,et al. Melatonin activates the Nrf2‐ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model , 2012, Journal of pineal research.
[116] A. Cuadrado,et al. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. , 2012, Oncogene.
[117] Takafumi Suzuki,et al. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. , 2012, Free radical biology & medicine.
[118] Masaaki Komatsu,et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis , 2012, Proceedings of the National Academy of Sciences.
[119] E. Jakubowska-Dogru,et al. Rosiglitazone treatment reduces hippocampal neuronal damage possibly through alleviating oxidative stress in chronic cerebral hypoperfusion , 2012, Neurochemistry International.
[120] I. Petrache,et al. Pathogenesis of chronic obstructive pulmonary disease. , 2012, The Journal of clinical investigation.
[121] A. Cuadrado,et al. α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. , 2012, Human molecular genetics.
[122] H. Aburatani,et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.
[123] P. Rada,et al. Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis , 2012, Molecular and Cellular Biology.
[124] P. Rabinovitch,et al. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. , 2012, Human molecular genetics.
[125] A. Hengstermann,et al. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease. , 2012, Chemical research in toxicology.
[126] A. Dinkova-Kostova,et al. Glucosinolates and isothiocyanates in health and disease. , 2012, Trends in molecular medicine.
[127] Jeffrey N Keller,et al. Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions. , 2012, Biochimica et biophysica acta.
[128] T. Morgan,et al. Nrf2-regulated phase II enzymes are induced by chronic ambient nanoparticle exposure in young mice with age-related impairments. , 2012, Free radical biology & medicine.
[129] Chun-Yan Li,et al. Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways , 2012, Neuroscience Letters.
[130] P. Narasimhan,et al. Minocycline-Preconditioned Neural Stem Cells Enhance Neuroprotection after Ischemic Stroke in Rats , 2012, The Journal of Neuroscience.
[131] J. Li,et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. , 2012, Free radical biology & medicine.
[132] R. S. Sohal,et al. The redox stress hypothesis of aging. , 2012, Free radical biology & medicine.
[133] H. Soininen,et al. Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease , 2012, Progress in Neurobiology.
[134] S. Niture,et al. Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis* , 2012, The Journal of Biological Chemistry.
[135] A. Wyttenbach,et al. In Vitro and in Vivo Aggregation of a Fragment of Huntingtin Protein Directly Causes Free Radical Production* , 2011, The Journal of Biological Chemistry.
[136] M. Modo,et al. Targeting the Nrf2–Keap1 antioxidant defence pathway for neurovascular protection in stroke , 2011, The Journal of physiology.
[137] Na Chen,et al. Resveratrol Pretreatment Attenuates Cerebral Ischemic Injury by Upregulating Expression of Transcription Factor Nrf2 and HO-1 in Rats , 2011, Neurochemical Research.
[138] S. Liebner,et al. Current concepts of blood-brain barrier development. , 2011, The International journal of developmental biology.
[139] G. Sykiotis,et al. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson’s disease , 2011, Disease Models & Mechanisms.
[140] Abhinav K. Jain,et al. Src Subfamily Kinases Regulate Nuclear Export and Degradation of Transcription Factor Nrf2 to Switch Off Nrf2-mediated Antioxidant Activation of Cytoprotective Gene Expression* , 2011, The Journal of Biological Chemistry.
[141] Wen Li,et al. Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[142] Gang Chen,et al. Role of the Nrf2‐ARE pathway in early brain injury after experimental subarachnoid hemorrhage , 2011, Journal of neuroscience research.
[143] T. Toki,et al. Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. , 2011, Archives of biochemistry and biophysics.
[144] C. Piantadosi,et al. Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression* , 2011, The Journal of Biological Chemistry.
[145] A. Dinkova-Kostova,et al. The cytoprotective role of the Keap1–Nrf2 pathway , 2011, Archives of Toxicology.
[146] K. Tufekci,et al. The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease , 2011, Parkinson's disease.
[147] M. Ekberg,et al. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties. , 2011, Free radical biology & medicine.
[148] P. Rada,et al. SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.
[149] H. Kaplan,et al. Circulating Reactive Oxidant Causes Apoptosis of Retinal Pigment Epithelium and Cone Photoreceptors in the Mouse Central Retina , 2011, Ophthalmology and eye diseases.
[150] T. Kensler,et al. When NRF2 talks, who's listening? , 2010, Antioxidants & redox signaling.
[151] A. Cantin. Cellular response to cigarette smoke and oxidants: adapting to survive. , 2010, Proceedings of the American Thoracic Society.
[152] J. Liao,et al. NF‐κB and innate immunity in ischemic stroke , 2010, Annals of the New York Academy of Sciences.
[153] M. Sporn,et al. Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. , 2010, Free radical biology & medicine.
[154] T. Pufe,et al. Sulforaphane suppresses LPS-induced inflammation in primary rat microglia , 2010, Inflammation Research.
[155] D. Crawford,et al. The Ubiquitin-conjugating Enzyme UbcM2 Can Regulate the Stability and Activity of the Antioxidant Transcription Factor Nrf2* , 2010, The Journal of Biological Chemistry.
[156] A. M. Martín-Moreno,et al. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease , 2010, Glia.
[157] B. Strooper. Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process , 2010 .
[158] Mihee M. Kim,et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.
[159] F. Khodagholi,et al. Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid beta formation in NT2N neurons. , 2010, Biochimie.
[160] G. Fiskum,et al. Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation , 2009, Journal of neuroscience research.
[161] A. I. Rojo,et al. The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK‐3beta: connecting neurotransmission with neuroprotection , 2009, Journal of neurochemistry.
[162] A. Cuadrado,et al. Role of microglial redox balance in modulation of neuroinflammation , 2009, Current opinion in neurology.
[163] D. MacEwan,et al. Lipopolysaccharide-Induced Expression of NAD(P)H:Quinone Oxidoreductase 1 and Heme Oxygenase-1 Protects against Excessive Inflammatory Responses in Human Monocytes , 2008, The Journal of Immunology.
[164] S. Petri,et al. Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis , 2008, Journal of neuropathology and experimental neurology.
[165] M. L. de Ceballos,et al. The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation1 , 2008, The Journal of Immunology.
[166] C. Iadecola,et al. Nuclear Factor-κB Activation and Postischemic Inflammation Are Suppressed in CD36-Null Mice after Middle Cerebral Artery Occlusion , 2008, The Journal of Neuroscience.
[167] L. Franco,et al. Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[168] Jing Zhao,et al. Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury , 2007, The Journal of Neuroscience.
[169] C. Glass,et al. Expression of Nrf2 in Neurodegenerative Diseases , 2007, Journal of neuropathology and experimental neurology.
[170] A. I. Rojo,et al. Glycogen Synthase Kinase-3β Inhibits the Xenobiotic and Antioxidant Cell Response by Direct Phosphorylation and Nuclear Exclusion of the Transcription Factor Nrf2* , 2006, Journal of Biological Chemistry.
[171] F. Hashemi,et al. Corticotropin Releasing Factor (CRF) Activation of NF-κB-Directed Transcription in Leukocytes , 2006, Cellular and Molecular Neurobiology.
[172] F. Bach,et al. Heme Oxygenase-1 Modulates the Expression of Adhesion Molecules Associated with Endothelial Cell Activation1 , 2004, The Journal of Immunology.
[173] T. Murphy,et al. NF-E2-related Factor-2 Mediates Neuroprotection against Mitochondrial Complex I Inhibitors and Increased Concentrations of Intracellular Calcium in Primary Cortical Neurons* , 2003, Journal of Biological Chemistry.
[174] E. Zandi,et al. Lipopolysaccharide Induces Rac1-dependent Reactive Oxygen Species Formation and Coordinates Tumor Necrosis Factor-α Secretion through IKK Regulation of NF-κB* , 2001, The Journal of Biological Chemistry.
[175] S. Bolesta,et al. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. , 2000, Clinical therapeutics.
[176] D. Stephenson,et al. Transcription Factor Nuclear Factor-Kappa B is Activated in Neurons after Focal Cerebral Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[177] Y. Panahi,et al. Oxidative stress in neurodegenerative diseases: a review , 1969 .
[178] Sangdun Choi,et al. Cigarette smoke and related risk factors in neurological disorders: An update. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[179] R. León,et al. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. , 2016, Pharmacology & therapeutics.
[180] S. Correia,et al. Type 2 diabetic and Alzheimer's disease mice present similar behavioral, cognitive, and vascular anomalies. , 2013, Journal of Alzheimer's disease : JAD.
[181] B. de Strooper. Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. , 2010, Physiological reviews.